E. coli epidemic baffles doctors

A highly virulent strain of E. coli that has already killed two people and infected around 800 (most of whom live or had visited northern Germany) has proved an enigma for epidemiologists.

Written byCristina Luiggi
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

MAXEXPHOTO / DREAMSTIME.COM

A highly virulent strain of E. coli that has already killed two people and infected around 800 (most of whom live or had visited northern Germany) has proved an enigma for epidemiologists. In particular, they are at a loss to explain the unusually high number of cases of haemolytic uraemic syndrome (HUS), a severe kidney illness, that the bacteria has caused. The epidemic has been linked to the consumption of raw cucumbers, tomatoes, and lettuce and has affected mostly women, ScienceInsider reports. According to Nature, a clinical trial for an experimental antibody called eculizumab (brand names Soliris or Alexion) is currently underway as a treatment for the infection.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies